The global biotechnology market was valued at USD 761.5 billion in 2024 and is forecast to reach USD 1,315.9 billion by 2033. The market is expected to grow at a CAGR of 6.27% during the forecast period 2025-2033. Major growth drivers include increasing R&D in personalized medicine, advancements in genetic engineering, and growing demand for sustainable agriculture. This market plays a significant role across healthcare, agriculture, and environmental sectors. 

Study Assumption Years

• Base Year: 2024

• Historical Year/Period: 2019-2024

• Forecast Year/Period: 2025-2033

Biotechnology Market Key Takeaways

• Current Market Size: USD 761.5 Billion in 2024

• CAGR: 6.27% during 2025-2033

• Forecast Period: 2025-2033

• Innovation in gene editing, personalized medicine, and genetic research is the primary catalyst driving the market.

• Rising incidence of chronic diseases increases demand for biopharmaceuticals and precision medicines.

• Adoption of sustainable farming solutions through biotechnology is growing due to global population pressure and limited cultivable land.

• Bioinformatics and information technology integration optimizes biotechnology R&D.

• Bioremediation technologies and biofuels support environmental sustainability and market growth.

Sample Request Link: 

https://www.imarcgroup.com/biotechnology-market/requestsample

Market Growth Factors

The biotechnology market growth is largely propelled by ongoing innovations in gene editing techniques such as CRISPR-Cas9 technology, enabling precise genetic modification across medicine, agriculture, and industrial applications. This progress fuels novel gene therapies for genetic disorders and cancers, alongside engineered microbes for pharmaceuticals and industrial enzymes.

Increasing demand for personalized medicine is another significant growth factor. Advances in genomic sequencing enable tailored therapies that align with individual genetic profiles, enhancing treatment efficacy and reducing side effects. The market emphasis on biopharmaceuticals like monoclonal antibodies and gene therapies reflects this trend, making personalized medicine a crucial development.

The need for sustainable agricultural solutions boosts the adoption of biotechnological methods such as genetically modified crops with enhanced yield and pest resistance, and biopesticides with reduced environmental impact. Biotechnology optimizes plant traits for climate resilience and nutrient efficiency, addressing food security while minimizing ecological footprints.

Market Segmentation

By Product Type:

• Instruments: Essential tools enabling precise analysis and experimentation in research and diagnostics.

• Reagents: Crucial components fueling experimental processes, facilitating accurate results.

• Software and Services: Encompasses data analysis, visualization, integration solutions, consulting, training, and technical support enhancing efficiency.

By Technology:

• Nanobiotechnology: Integrates nanoscale materials with biological systems to revolutionize drug delivery and diagnostics.

• Tissue Engineering and Regeneration: Develops functional tissues to address organ shortages and medical needs.

• DNA Sequencing: Enables comprehensive genomic analysis guiding personalized medicine and disease understanding.

• Cell-Based Assays: Offers insights into cellular behavior supporting drug development and toxicity testing.

• Fermentation: Core bioprocessing method producing biofuels, pharmaceuticals, and enzymes.

• PCR Technology: Amplifies DNA critical for diagnostics and genetic research.

• Chromatography: Separates biomolecules precisely for drug purification and analytical processing.

• Others: Various other biotechnological methods driving innovation.

By Application:

• Healthcare: The largest segment, driving innovations in diagnostics, treatment, and personalized medicine.

• Food and Agriculture: Focuses on improving crops and sustainable farming solutions.

• Natural Resources and Environment: Solutions impacting environmental management.

• Industrial Processing: Applications in industrial biotechnology processes.

• Bioinformatics: Combines IT and biology to optimize research and development.

• Others: Additional applications contributing to the biotechnology market.

Regional Insights

North America dominates the biotechnology market, attributed to a robust ecosystem of research, innovation, and industry collaboration. The region benefits from strong R&D investments, established regulatory frameworks, and a strong presence of leading biotech companies and research institutions. Entrepreneurial emphasis and venture capital also accelerate commercialization, reinforcing North America's influential role in shaping the global biotechnology landscape.

Recent Developments & News

In May 2025, Biogen partnered with City Therapeutics to develop RNA interference therapies for central nervous system diseases, focusing on systemic RNAi treatment using combined technologies. Biocon Biologics launched a biosimilar drug in Japan targeting psoriasis and psoriatic arthritis. Novartis announced a USD 23 Billion investment plan in the US for biotech and pharmaceutical expansion over five years, including new facilities and jobs. Amgen invested an additional USD 900 Million in Ohio biologics manufacturing. Roche opened an innovation center in Boston to lead R&D in cardiovascular and metabolism diseases and support AI-driven drug discovery.

Key Players

• Amgen Inc.

• Biocon Limited

• Biogen Inc.

• F. Hoffmann-La Roche AG

• Genmab A/S

• Lonza Group AG

• Novartis AG

• Novo Nordisk A/S

• Pfizer Inc.

• Regeneron Pharmaceuticals Inc.

• Seagen Inc.

• Syngenta AG

• Vertex Pharmaceuticals Incorporated

Ask For Customization Note:

https://www.imarcgroup.com/request?type=report&id=5785&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302